Jun 22, 2016

feedback@dealstreetasia.com June 22, 2016: &nbsp CASH Capital Investment Management Co Ltd and Legend Capital have led a series B round in a medical device logistics provider, while Chinese startup UrWork has raised $46 million in a pre-Series B round. CASH Capital, Legend lead Series B round in Guoke Hengtai  Beijing-based CASH Capital Investment Management Co, Ltd. and Legend Capital have led a series B round worth millions in Guoke Hengtai Medical Technology Co., Ltd, a medical device supply chain service provider. Northern Light Venture Capital , Aeon Life, Frontline Bioventures and Blue Ridge China also participated in the round. “(We) optimize resources allocation and help suppliers, logistics companies and medical firms to achieve efficiency,” said Liu Bing, founder of Guoke Hengtai (Beijing) Medical Technology. CASH Capital is an investment arm of the Chinese Academy of Science Holdings. Legend Capital had in June reportedly invested $26 million in Kaola FM, an audio program network run by China’s AutoRadio Group. UrWork secures $46m from Yintai Land UrWork, which provides co-working space to individuals and small companies, has secured strategic investment of $46 million in a pre-Series B round from Chinese commercial property developer Yintai Land and Zhongrong International Trust Co Ltd. UrWork plans to open in 36 locations across 16 cities in China. That will equate to 120,000 square meters of office space with 20,000 desks. The company also offers legal and accounting services, marketing, healthcare, cloud computing, investor introduction and events to its members. UrWork has been gaining traction in the past year. In early March, the company, founded by a former executive at China Vanke Co., Ltd. secured over $31 million in a series A round from Gopher Asset Management Co Ltd. Also Read: